|
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical research trials and Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation clinical trial. Human subjects often obtain the finest healthcare possible for their Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation  Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
For Condition: Hepatitis B
Status: Recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: This is a phase IIIb comparitive study of entecavir 1.0 mg QD vs adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for up to 96 weeks.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 16 Years/
Genders: Both
Protocol Entry Criteria: Inclusion - CP score > 7 - HBV viremia Exclusion - ALT > 15 - HIV/HCV/HDV coinfection
Total Enrollment:
Location and Contact Information:
Local Institution *Recruiting*
Farmington, Connecticut,
United States
Recruiting
Local Institution *Recruiting*
Los Angeles, California,
United States
Recruiting
Local Institution *Recruiting*
Minneapolis, Minnesota,
United States
Recruiting
Local Institution *Recruiting*
Richmond, Virginia,
United States
Recruiting
Local Institution *Recruiting*
San Diego, California,
United States
Recruiting
Local Institution *Recruiting*
Oklahoma City, Oklahoma,
United States
Recruiting
Local Institution *Recruiting*
Boston, Massachusetts,
United States
Recruiting
Local Institution *Recruiting*
Orange, California,
United States
Recruiting
Local Institution *Recruiting*
Atlanta, Georgia,
United States
Recruiting
Local Institution *Recruiting*
Chicago, Illinois,
United States
Recruiting
Local Institution *Recruiting*
Honolulu, Hawaii,
United States
Recruiting
Local Institution *Recruiting*
Miami, Florida,
United States
Recruiting
Local Institution *Recruiting*
Louisville, Kentucky,
United States
Recruiting
Local Institution *Recruiting*
Philadelphia, Pennsylvania,
United States
Recruiting
Local Institution *Recruiting*
Indianapolis, Indiana,
United States
Recruiting
Local Institution *Recruiting*
Tucson, Arizona,
United States
Recruiting
Local Institution *Recruiting*
Royal Oak, Michigan,
United States
Recruiting
Local Institution *Recruiting*
Phoenix, Arizona,
United States
Recruiting
Local Institution *Recruiting*
New York City, New York,
United States
Recruiting
Local Institution *Recruiting*
Baltimore, Maryland,
United States
Recruiting
Local Institution *Recruiting*
Iowa City, Iowa,
United States
Recruiting
Local Institution *Recruiting*
Valhalla, New York,
United States
Recruiting
Local Institution *Recruiting*
San Francisco, California,
United States
Recruiting
Local Institution *Recruiting*
Dallas, Texas,
United States
Recruiting
Additional Information:
Study ID Numbers: AI463-048;
Study Start Date: July 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065507
Other Hepatitis B Studies:
1. Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
2. Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
3. Hepatitis B Vaccine Clinical Trial
4. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
5. The Tolerance of HIV-Infected Patients with Herpes Group Virus Infections to Oral Doses of FIAU
Related Studies:
Other Hepatitis B Clinical Trials
Other Indiana Clinical Trials
Other Indianapolis Clinical Trials
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
|
|
|
|
|
|
|
|
